Martine Rothblatt

2021

In 2021, Martine Rothblatt earned a total compensation of $3.5M as Chairperson and Chief Executive Officer at United Therapeutics, a 27% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,132,813
Salary$1,367,858
Other$10,400
Total$3,511,071

Rothblatt received $2.1M in non-equity incentive plan, accounting for 61% of the total pay in 2021.

Rothblatt also received $1.4M in salary and $10.4K in other compensation.

Rankings

In 2021, Martine Rothblatt's compensation ranked 3,816th out of 12,406 executives tracked by ExecPay. In other words, Rothblatt earned more than 69.2% of executives.

ClassificationRankingPercentile
All
3,816
out of 12,406
69th
Division
Manufacturing
1,559
out of 5,492
72nd
Major group
Chemicals And Allied Products
633
out of 2,368
73rd
Industry group
Drugs
562
out of 2,089
73rd
Industry
Pharmaceutical Preparations
392
out of 1,536
75th

Pay ratio

Martine Rothblatt's Pay$3,511,071
Median Employee's Pay$189,023
Pay Ratio

19

to 1

In 2021, the annual total compensation of Martine Rothblatt was $3,511,071.

The annual total compensation of the median employee at United Therapeutics was $189,023.

The ratio of Martine Rothblatt's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on April 29, 2022.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2021.

2021

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2021

James Edgemond

United Therapeutics

Chief Financial Officer

2021

Paul Mahon

United Therapeutics

General Counsel

News

You may also like